ClinicalTrials.gov
ClinicalTrials.gov Menu

Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01016769
Recruitment Status : Completed
First Posted : November 19, 2009
Last Update Posted : June 18, 2018
Sponsor:
Collaborators:
NATL COMP CA NETWORK
Pfizer
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2018
  Actual Study Completion Date : June 2018